Keylika

Redefining the Standard of Care for Iron Deficiency Anemia

Y CombinatorSummer 2022ActiveHealthcareTherapeuticsAI-powered Drug DiscoveryMedical DevicesDrug DeliveryNanotechnology

What they do

Problem

Existing iron deficiency anemia treatments often cause gastrointestinal side effects with oral iron or carry risks, costs, and burdens with IV infusions.

Solution

Keylika develops a new small-molecule iron drug delivered via a wearable skin patch to treat iron deficiency anemia with improved safety, efficacy, and tolerability.

Who it's for

Patients with iron deficiency anemia and the clinicians/healthcare systems that prescribe and administer anemia treatments.

Founders

Buddha Chaudhuri

Founder

Buddha spearheaded the technology development of a microneedle-based biosensor from lab-to-fab for a Series B stage medtech startup. Having worked across 3 continents and 6 countries, he has been instrumental in developing novel healthcare technologies in leading global research institutes and biotech companies, for the last 15 years. Buddha earned his PhD from Imec / KU Leuven in Belgium, in Drug Delivery Microsystems. He also pursued a Postdoc at UC San Francisco (UCSF) / UC Berkeley.

LinkedIn · X

Frederik Ceyssens

Founder

With a deep passion for diverse technologies, Frederik is truly a multi-domain expert. From tiny moving machines to nuclear space rockets, and electrical circuits to medical devices – Frederik has pursued an illustrious scientific career over the last 15 years developing key microtechnologies for lifescience applications. He also founded a venture-backed neurotech startup to cure blindness. Frederik holds a PhD and a Masters in IC design as well as a Bachelors' in Medicine.